Tumour necrosis factor‐dependent parasite‐killing effects during paroxysms in non‐immune Plasmodium vivax malaria patients

Plasmodium vivax malaria infections in non‐immune individuals manifest as periodic clinical episodes of fever with chills and rigors known as paroxysms. We have demonstrated that in non‐immune patients the period of paroxysm is associated with the transient presence of plasma factors which kill gametocytes, the intra‐erythrocytic sexual stages of the malaria parasite which transmit the infection from humans to mosquito, rendering them non‐infectious to mosquitoes. Gametocytc killing in paroxysm plasma is mediated by tumour necrosis factor (TNF) acting in conjunction with other essential serum factor(s). Plasma TNF levels were elevated during a paroxysm. In semi‐immune individuals from a P. vivax‐endemic area clinical symptoms of malaria are mild and the parasite killing factors are not induced during paroxysm. Serum TNF levels were correspondingly lower in endemic patients during a paroxysm. Human peripheral blood mononuclear cells (PBMC) can be stimulated in vitro by extracts of P. vivax blood stage parasites to produce TNF and associated parasite killing factor(s), thus simulating in vitro the events that occur during a paroxysm, this being the release of parasite exo‐antigens by rupturing schizonts and the subsequent induction of PBMC to produce TNF and other parasite‐killing factors. We were able to show that convalescent serum from P. vivax semi‐immune individuals block the induction of TNF and parasite‐killing factors by malaria antigens in vitro, presumably through antibodies that neutralize parasite exo‐antigens. Thus, individuals living in malaria‐endemic areas appear to acquire clinical immunity to malaria by avoiding their induction during infection; we have shown that one such mechanism is the neutralization of parasite exo‐antigens that induce the production of parasite killing factors.

[1]  K. Mendis,et al.  Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential , 1991, The Journal of experimental medicine.

[2]  K. Mendis,et al.  Anti-parasite effects of cytokines in malaria. , 1990, Immunology letters.

[3]  J. Playfair,et al.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. , 1990, Immunology.

[4]  K. Mendis,et al.  Human T cell proliferative responses to Plasmodium vivax antigens: evidence ofimmunosuppression following prolonged exposure to endemic malaria , 1990, European journal of immunology.

[5]  K. Mendis,et al.  Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates. , 1990, Journal of immunology.

[6]  C. Mendis,et al.  Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. , 1990, The American journal of tropical medicine and hygiene.

[7]  P. Vassalli,et al.  Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Molyneux,et al.  Tumor necrosis factor and disease severity in children with falciparum malaria. , 1989, The New England journal of medicine.

[9]  V. Kindler,et al.  Prevention of experimental cerebral malaria by anticytokine antibodies. Interleukin 3 and granulocyte macrophage colony-stimulating factor are intermediates in increased tumor necrosis factor production and macrophage accumulation , 1988, The Journal of experimental medicine.

[10]  I. Clark,et al.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. , 1987, Journal of immunology.

[11]  I. Clark,et al.  Possible roles of tumor necrosis factor in the pathology of malaria. , 1987, The American journal of pathology.

[12]  V. Nussenzweig,et al.  Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. , 1987, Journal of immunology.

[13]  Clark,et al.  Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.

[14]  I. Clark DOES ENDOTOXIN CAUSE BOTH THE DISEASE AND PARASITE DEATH IN ACUTE MALARIA AND BABESIOSIS? , 1978, The Lancet.

[15]  I. McGregor,et al.  Effects of Heavy and Repeated Malarial Infections on Gambian Infants and Children , 1956, British medical journal.

[16]  W. H. Taliaferro,et al.  The Effect of Immunity on the Asexual Reproduction of Plasmodium Brasilianum , 1944 .

[17]  R. Hill,et al.  Observations on the Course of Malaria in Children in an Endemic Region. , 1943 .

[18]  J. Playfair,et al.  The malaria vaccine: anti-parasite or anti-disease? , 1990, Immunology today.

[19]  J. Tavernier,et al.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. , 1987, Clinical and experimental immunology.

[20]  K. Mendis,et al.  Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.